Nora Signs an Exclusive Agreement Biopharmaceutical Partner to Launch a Biosimilar in Canada
Shots:
- Nora collaborates with a biopharmaceutical partner to obtain the commercial rights for a biosimilar drug
- The collaboration will support both private insurers and public formularies by reducing the costs of biosimilars & provide accessibility to patients for high quality affordable pharmaceutical products
- Nora Pharma's activities coordinate with the biosimilars transition policy adopted by several Canadian provinces
Ref: Newswire | Image: Stat News
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com